Bernard Van Eerdenbrugh

Novartis (Switzerland)Switzerland

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

26h-index3.8kcitations63works0.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?


Research Topics

Drug Solubulity and Delivery Systems(31), Crystallization and Solubility Studies(23), Analytical Chemistry and Chromatography(15), Protein purification and stability(10), Microencapsulation and Drying Processes(9)

Publications63 total

ACS Medicinal Chemistry Letters·2019· 36 citedOpen Access
W5093: Dissolution, free drug concentration and permeability of crystalline nanoparticle formulations: study using in situ fiber optic and potentiometric techniques
2015
Media and Additive Influences on the Amorphous Solubility of Ketoprofen
2013
Journal of Pharmaceutical Sciences·2012· 85 cited
Nanoscale Mid-Infrared Imaging for the Characterization of Pharmaceutical Systems
2012
Binary Blends of Poly(Vinylpyrrolidone) with Dextran and Maltodextrin as Model Systems for the Study of Miscibility
2012
Classification of the Crystallization Behavior of Amorphous Active Pharmaceutical Ingredients in Suspension
2012
Nanoscale Mid-Infrared Evaluation of the Miscibility Behavior of Blends of Dextran or Maltodextrin with Poly(vinylpyrrolidone)
Journal of the American Chemical Society·2012
page 1 of 4Next →

Frequent Co-authors

Patrick Augustijns(22), Lynne S. Taylor(22), Johan A. Martens(17), Guy Van den Mooter(16), Ludo Froyen(16), Jan Van Humbeeck(16), Jan Vermant(7), Michael Juhnke(5), Martin Wewers(4), Stefan Czyz(4), Jan Henrik Finke(4), Heike Bunjes(4), Arno Kwade(4), Guy Van den Mooter(4), Shweta A. Raina(3), Michael Lo(3), Kevin Kjoller(3), Curtis Marcott(3), Phillip E. Fanwick(3), Jared A. Baird(2)